Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.

CONTINUUM NOVUM : revenue, balance sheet and financial ratios

CONTINUUM NOVUM is a French company founded 15 years ago, specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé. Based in LE MANS (72000), this company of category PME shows in 2025 a net income positive of 77 k€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-05-02

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - CONTINUUM NOVUM (SIREN 530465293)
Indicator 2025 2024 2022 2021 2020 2019 2018 2017
Revenue N/C N/C N/C N/C N/C N/C N/C N/C
Net income 77 159 € 67 855 € 80 017 € 41 825 € 51 892 € 54 098 € 58 098 € 49 933 €
EBITDA N/C N/C N/C N/C N/C N/C N/C N/C
Net margin N/C N/C N/C N/C N/C N/C N/C N/C

Revenue and income statement

In 2025, CONTINUUM NOVUM generates positive net income of 77 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2017-2025: 50 k€ -> 77 k€.

Net income (2025) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

77 159 €

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 61%. Debt remains under control: the company retains capacity to raise new debt if needed. Financial autonomy (= Equity / Total assets x 100) reaches 56%. This high autonomy means the company finances most of its assets through equity, a sign of strength.

Debt ratio (2025) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

60.71%

Financial autonomy (2025) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

56.2%

Asset age ratio (2025) ?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Interpretation
< 50% : Recent assets
50-70% : Normal wear
> 70% : Aging assets

20.0%

Solvency indicators evolution
CONTINUUM NOVUM

Sector positioning

Debt ratio
60.71 2025
2022
2024
2025
Q1: 13.7
Med: 49.79
Q3: 129.09
Average

In 2025, the debt ratio of CONTINUUM NOVUM (60.71) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.

Financial autonomy
56.2% 2025
2022
2024
2025
Q1: 33.42%
Med: 53.72%
Q3: 72.08%
Good +10 pts over 3 years

In 2025, the financial autonomy of CONTINUUM NOVUM (56.2%) ranks above the median of the sector. This ratio represents the share of equity in total financing. This comfortable position offers an appreciable safety margin.

Liquidity ratios

The liquidity ratio (= Current assets / Current liabilities) stands at 209.04. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.

Liquidity ratio (2025) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

209.043

Liquidity indicators evolution
CONTINUUM NOVUM

Sector positioning

Liquidity ratio
209.04 2025
2022
2024
2025
Q1: 131.03
Med: 182.25
Q3: 258.64
Good +26 pts over 3 years

In 2025, the liquidity ratio of CONTINUUM NOVUM (209.04) ranks above the median of the sector. This ratio measures the ability to cover short-term debt with current assets. This comfortable position offers an appreciable safety margin.

Positioning of CONTINUUM NOVUM in its sector

Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé

Valuation estimate

Based on 277 transactions of similar company sales in 2025, the value of CONTINUUM NOVUM is estimated at 1 225 679 € (range 831 752€ - 1 923 260€). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.

Estimated enterprise value 2025
277 transactions
831k€ 1225k€ 1923k€
1 225 679 € Range: 831 752€ - 1 923 260€
NAF 5 année 2025

Valuation method used

Net Income Multiple
77 159 € × 15.9x = 1 225 680 €
Range: 831 752€ - 1 923 261€

Only this financial indicator is available for this company.

Valuation evolution

How is this estimate calculated?

This estimate is based on the analysis of 277 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)

Compare CONTINUUM NOVUM with other companies in the same sector:

Voir toutes les statistiques du secteur Commerce de détail de produits pharmaceutiques en magasin spécialisé

Frequently asked questions about CONTINUUM NOVUM

What is the revenue of CONTINUUM NOVUM ?

The revenue of CONTINUUM NOVUM is not publicly disclosed (confidential accounts filed with INPI).

Is CONTINUUM NOVUM profitable?

Yes, CONTINUUM NOVUM generated a net profit of 77 k€ in 2025.

Where is the headquarters of CONTINUUM NOVUM ?

The headquarters of CONTINUUM NOVUM is located in LE MANS (72000), in the department Sarthe.

Where to find the tax return of CONTINUUM NOVUM ?

The tax return of CONTINUUM NOVUM is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does CONTINUUM NOVUM operate?

CONTINUUM NOVUM operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.